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INTRODUCTION

The idea, popular among the

lai~,

that the amenorrhea

associated with the period of lactation gave protection against
conception is, of course. known to the medical profession to be
unfounded.

It is obvious to those interested, however, that

not all women fail to menstruate during lactation and that
pregnancY does occur in a reasonable number of instances
either before menses resume or after the qycle has re-established.
Likewise, the reappearance of menses does not seem to decrease
or influence the secretion of breast milk, therefore, the endocrine s,ystems responsible for lactation and menstruation
not necessarilY be

recipDocal~

m~

related.

An observation made some years ago and reported in 1943
b,y

Fortune indicates that Arapesh women do not resume menses

during lactation before the infant has cut its first inCisors,
although Caucasian women

~

menstruate earlier.

These wamen

are an inbred group (8000 or less) with a characteristic long
lactogenic interval.

Nursing for three years, which is common

among these women, does not produce amenorrhea for that length
of time. (1).
With these simple and gross observations in mind it was
decided to study the problem of the Nature of the Amenorrhea
of Lactation in Humans.
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II

REVIEW OF LITERATURE

A careful review showed

theartia~es

written on this

subject to be sparsely distributed throughout the literature.
Everyone agreed about the growth and development of the
breast and the process b.r which lactation occurs, but the
effect of lactation on the menstrual cycle has not been well
described.
Novak and Hoskins agree on the theory that at puberty
the ovarian hormones, estrogen and progesterone, will stimulate
the anterior pituitary to increase the secretion of a duct
growth factor (mammogenic hormone).

During pregnancy proges-

terone plus estrogen (placental hormones) causes an increased
secretion of lobule-alveolar growth factor and is responsible
for proliferation of alveolar ducts and lobules.
about

w~

Theories

lactation does not occur during pregnancy are, 1. that

the placenta produces a lactation suppressing agent,

~.

that the

distended uterus inhibits lactation, 3. that the secretion of
progesterone b.r the corpus luteum during pregnancy

1nhibits~

lactation, 4. that the lactogenic hormone is inadequate during
pregnancy and is increased 2-4 times within a short time after
parturition.

Novak's only comment about menstruation and ovula-

tion during lactation was to reiterate that OVUlation is followed

b.Y menstruation if fertilization does not take place, therefore,
menstruation without ovulation is possible but OVUlation without
menstruation is impossible unless pregnancy intervenes.
Hoskins (2) assumes that menstrual failure during lactation is due to the action of a mammary hormone exerted either
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directlY on the ovaries or via the anterior-pituitary to
cause a persist.nce of corpus luteum which in turn arrests
the cyclic process.

It is more probable that the Prolactin

Hormone is responsible for this.
One of the most informative papers published was one
by

-Paul Topkins (3) in 1943.

His purpose was to deternline

the extent of ovarian inhibition during lactation.

For his

study he chose to examine the endometrium by biopsy during
the period of lactation.

He assumes that i f progestational

(progesteronal) endometrium is formed, then ovulation has
taken place and that the absence of such an endometrium indicates, but does not prove, an absence of ovulation, (4).
further states that

~lure

of OVUlation cannot

definite~

He
be

established without microscopic study of the ovaries unless
you aSSUllle ovulation is always followed by lueeinization and
that luteinization always produces a secretory endometrium.
Sinee the endometrium

usual~

regenerates in three weeks

post-partum, except at the placental site)where about seven
weeks is required, Topkins began his biopsies at the 6th postpartum week.

He took 145 specimens from 28-women, eight colored

and twent,y white, who had had previous regular periods before
pregnancy and who were otherwise gynecologically normal.

Four

biopsies were taken from each patient and classified as estrogenic and progestational and the numeer of weeks post-partum
noted.

One hundred

thir~

genic - and of that 94% -

six (136) o. 94% proved to be estro15~

were poorly developed or

~po-
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estrogenic whereas 85% wer$ fairly well developed and constant
throughout the amenorrhea, showing mid-follicular phase (end of
1st week of cycle) endometrium.

The remaining 6% showed pro-

gestational endometrium and all were associated with the onset
of the first menstrual flow.
Topkins concluded that (l) the endometrium in lactation
amenorrhea shows diminished estrogen stimulation, (2) during
lactation the ovarian cycle is suppressed completely in amenorrhea
and incompletely in lactation menstruation, (3) on the basis of
animal experimentation, inhibition of ovarian activit,y is the
result of suppression of gonad atrophic activity of the hypophysis and that (4) suppression of gonadatrophic activit,y, in turn,
is due to the action of prolactin or else to a hormone of the
lactating mammary gland not yet isolated.
He suggests that 85% of cases of undifferentiated endometrium,as in the first week of the cycle, indicates that the
follicle is not fully developed and that 15% of cases with bypoplasia suggest that those follicles are regressing.

This study

indicates that in lactation amenorrhea there is inhibition of
ovarian activity, the follicles failing to mature to the point
of rupture.

Topkins also further concludes

tr~t

it is reason-

able to assume if luteinizing hormone is responsible for lactation amenorrhea then ovulation would be present, which it is not.
We now know, however, that pure Follicle Stimulating Hormone
will stimulclte the ovarian follicle to the point of morphological
development but does not cause the secretion of estrogen.
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The addition of Luteinizing Hormone (L.H.) is necessary to
produce estrogen and for rupture of follicles to occur, (5).
Another careful study is reported by Cherry (6), who ill
19a5-37 described the action of the mammary gland on the ovary.

His paper states that the mammary gland develops under the influence of estrogen and when prlmed by the corpus luteum hormone the administration of estrogen wiLl stimulate lobularalveolar development.

During pregnancy estrogen is present in

large amounts in the Circulation, reaching a peak shortly before parturition and falling

marked~

after parturition.

This

fall in estrogen releases the inhibitory action on the pituitary
gland and prolactin or lactogenic hormone is released under the
sucking reflex stimulus, which is a function of the bypothalmus.
Cherry then explains the lack of menstruation in a majority of
women during lactation on the basis that there is a low estrogen
level in the circulation that is inhibited by some antagonistic
hormone action, from the lactating breast, prevent:i.ng the maturation of the ovarian follicle.

This action,he

thinks~varies

intensity and it is assumed that when ovulation

j

in

menstruation

or pregnancy do occur during lactation that the pituitary has
overcome this

inhib~Ltion.

Cherry, too, assumes the

ovari~

failure is probablY secondary to pituitary suppression.

Cherry's

investigation was based on a theory that the breast produced a
substance at tlle beginning of lactation which inhibited maturation of the ovarian follicle and ovulation.

He injected alcohol

precipitates of pregnancy urine and extracts of lactating mammary
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gland into albino rats.

In the gonadatrophic injected controls

corpora hemorrhagica and corpora lutea developed in every instance.

In the controls injected with extracts of mammary gland

no change was noted either macroscopically or microscopically.
When the two extracts were mixed in the same s-,fringe and given
together the result in most instances was complete absence of
corpora hemorrhagica

~d

corpora lutea.

Follicular development

was present in the majority of instances, but in some animals
this too was absent) as confirmed b.Y negative vaginal smears and
microscopic sections.
FUrther work on the rabbit proved there was a definite
inhibitory action of the lactating mammary gland on the ovary.
Griffith and McBride (7) in 1939 reported 21-post par tum
patients examined and biopsied at intervals varying from three
to twenty-four weeks.

Ten patients nursed their babies from

two to nine months and eight of these, 80%, began to have menstrual periods and ovulation only after weaning.
duration of nursing was
at five months and

3~-months,

The average

followed by anovulatory flow

qy the first ovulation at 5;-months. Two

patients, 20%, had regular menses (Ovulatory) during their
period of lactation.
ning

One of these had menstrual periods begin-

after two months, ovulation after five months.

her child seven months.

She nursed

Another had menstrual periods ri-

established after six months, OVUlation after

6·~-months.

She

weaned her child at age nine months.
Eleven patients unable to nurse babies had menstrual
periods beginning on an average of two months post-partum and
OVUlation at five months post-partum or later.
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In 95% of these cases an anovulatory flow preceded ovulation.

These authors

assume~as

is immediately

does

Topkins~that

suppressed~probably

Pituitary Gonadatrophin

due to the lactogenic hormone

or some other uWol0wn internal secretion.
Furtller studies along the same theme done by Kurzrok, Lass
and Smelser (8) consisted of biopsies done on thirty women who

were simultaneously lactating and having regular menstrual cycles.
They establish in their series that 65% of these cycles are sterile
or anovulatory periods.

A year later(9), in 1938, these same

authors presented another study relating to the time of human
ovulation

dur~g

lactation, in which they again biopsied post-

partum women who were nursing regularly and having regular catamenia.

The presence of secretory endometrium indicates ovulation

and the presence of non-secretory endometrium within ten days of
the succeeding menstrual flow indicates an anovulatory cycle in
their series.

Forty-seven women were studied by biopsy at four

week intervals and 55% of these cycles were anovulatory and 45%
were ovulatory.
Pregnandiol output in the urine is now accepted as an index
of corpus luteum activit¥ in both the pregnant and non-pregnant
woman.

Fifty-one cases of pregnandiol excretion were studied

during the first post-partum week by Wilson, Randall and Osterbery
showing evidence that some pregnandiol is present immediately
after parturition but in amounts less than those found antepartum (10).

Estimates of pregnandiol on the 4th post-partum

day showed 45% negative, 21% minimal and 34% with a mean value
of 2.75 to 6-mgms per 24-hours.

This may indicate some corpus
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luteum function post-partum and its association with lactation
is not yet known.
Robinson (11) discusses the subject from the opposite
point of view, namely:

if menstrual periods are resumed or if

pregnancy does occur during lactation does milk secretion stop?
He interviewed over 600 mothers regarding the age of weaning and
the time their menstrual periods resumed.

He concluded that men-

struation is neither a reason for weaning nor a cause for failure
of lactation;

these functions seem to be independent of lactation.

In the series of women pregnant and simultaneously lactating,
maqy

EV

pregnancies went unnoticed until foetal movements were felt.

this time the foetus is 18-20 weeks old and the nursing in-

fant seven months old which means that adequate lactation had
continued for five months of pregnancy.

~

seven months lacta-

tion normally diminishes so the lowered output after that could
not be attributed to the pregnancy.
Other work based on arumal experimentation has been published and where possible has been applied in theory to humans.
Bates, Lahr and Riddle (12) in 1935 showed that data concerning
the action of F.S.H. and prolactin on the ovary and sex accessories of fowls fell into two contrasting groups demonstrating
directly opposite effects.

Prolactin stopped ova production and

caused decrease in ovarian weight.

F.S.H. stimulated ova pro-

duction, stopped laying and increased ovarian weight markedly.
Prolaotin decreased oviduota1 and uterine Size, comb size and
pubic bone width, whereas F.S.H. increased the size of these
structures.
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Lahr and Riddle (12) injected Prolactin into non-lactating
rats and observed suspension of two to four estrous cycles
with large undegenerated corpora lutea in the ovaries.
gesterone produced no such effect.

Pro-

Riddle and Bates (13) in

1933 showed prolactin to cause regression in the weight of
the testis of a pigeon and concluded the same to be true of
the ovary.

The.y therefore offer the possibility that the gonad-

stimulating (sex-maturing) hormone is heM in abeyance by circulating prolactin.

Turner and Meitus (14-15) showed that in

rabbits the lactogenic hormone which was low during pregnancy
increased 2 - 4 times after parturition and this increase was
not influenced by a simultaneous pregnancy.
Collip, Sel3'e and Thomson

(l6~

FinalJ.¥ in 1934

presented the idea that the

stimulus of sucking was also involved in this problem via the
~pothalmus.

They believe suckling stimulates the anterior-

pituitary to produce prolactin and to mOdifY its activity
toward the ovary so that corpora lutea

09

post-partum OVUlation

long retain their healthy structure and active function while
further ovulation and phenomena of estrus are inhibited.
From these articles it is evident that much is still to
be learned about the pqysiological actions of these endocrine
glands during lactation.
Further light was shed on the subject by Albright, Smith
and Dodge (17) when in their presentation of a new method of
ass~

of pituitary F.S.H. they review a case of secondary

amenorrhea with perSistent lactation after 2i-years.

The F.S.H.

output per-24-hours in this patient fell within the normal
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limits instead of being suppressed and the,y promised a further investigation of the problem of lactation amenorrhea.

III

PURPOBE

The idea that the F.S.H. output per 24-hours may consistently be within normal limits is the basis for the following investigation.

The hormone level will be determined

b.Y urinary assay and correlated with the simUltaneous endometrial biops.y findings in an attempt to not only confirm
other work done on the inoidence of ovulation during lactation but also to determine the true status of the pituitary
activity •

IV

EXPERIMENTAL PROCEDURE

Thirteen colored females were selected from the PostPartum Clinio at the Louisville General Hospital at the time
of their regular six weeks post-partum examination.

These

women were biopsied and an assay of urinary F.B.H. was taken
simultaneously.

All of the patients were in good general

health and had had no previous menstrual irregularities.

These

women were examined at various intervals between their 6th and
19th post-partum week.

The incidence of non-secretory and secre-

tory endometrium was observed;

the level of Pituitary F.B.H.

output per 24-hours was determined and the presence or absence
of menstruation was noted during their period of lactation •
The data is compiled in charts and is here discussed.

One case

of persistent amenorrhea in a patient l4-months post-partum
is presented.
Discussion regarding the method of hormone assay is needed.
The procedure used is that described and confirmed b,y Smith,

An eight hour overnight

Albright and Dodge, (17-18), in 1943.

urine specimen is filtered and if necessary acidified with
acetic
g~acia~acid.
One gram of sodium chloride per 100 cc of urine
is added and four volumes of 95%

etny~

alcohol.

This is cooled

overnight in the refrigerator and the precipitate collected in
a 250 cc centrifuge bottle.

The precipitate is washed with anhy-

drous ether and dried overnight in a vacuum dessicator.

The pre-

cipitate is then redissolved in water, 30-45 cc, and dialysized
for four hours against running tap water DO remove impurities
and render the specimen less toxic.

The product of dialysis is

re-precipitated b,y adding .1 gm

to the

NaC~

(45-cc) and f:.:>ur volumes of ethyl alcohol.

who~e

specimen

This is cooled over-

night and the precipitate collected in a 50 cc centrifuge tube
and again dried with anhydruus ether overnight in a dessicator.
This precipitate 1s stable at room

temper~ture

and when ready

for use is dissolved in 5.5 cc of distilled water and kept refrigerated until the assay is completed.

White mice 19 to 20

days old and weighing 7-10 gms are used for the assay and are
injected subcutaneously in the back with 2;1-cc of test solution
over a period of three days, receiving

~

cc at each injection.

Twant,y-four hours after the last injection the mouse is autopsied
and the uterine weight determined by removing it, pressing it
between filter paper to remove the exc&ss tissue fluid and
weighing it on a balance.
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One mouse unit ot hormone is the amount required to
produce 100-150% increase in the size of the uterus (weight).
NorInalIy the uterus in animals injected with saline as controls weighed 3.7 mgs
et ale

I or - .9 mgms as reported b.1 Albright,

In this series, and with this particular strain of

mice, 14 animals kept as controls had an average uterine weight
of 3.28 mgm.

The final precipitate contains all the hormone

excreted b.Y that patient in an eight hour period, therefore i t
2.5 cc of this 5.5 cc solution contains one or more Mouse Units
(Mu) as indicated b,y a positive test, then the 5.5 cc will contain 2.2 Mu.
6.6 Mu.

~

The patient's output for 24-hours would then be
making appropriate dilutions with water the original

specimen may be further

ass~ed

for higher levels of F.S.H.

The level for normal regularly menstruating women, not
pregnant and not lactating, is more than 6.6 and less than 53 Mu
units in 24-hours, according to standards reported b,y Albright,
Smith and Dodge.

These authors stress the importance ot the

F.S.H. test, in that at present it is the only anterior pituitary
hormone that can be

ass~ed

applied further clinically.

easily and also suggest

tl~t

it be

The procedure is simple in technique,

its main fault being the amount of time required to prepare one
specimen for

ass~

(44-92 hours) - (5).

Regarding the use of the alcohol precipitate test, Heller
and Heller (19) cite five advantages of this method over other
extractions, chiefly the tannic acid or tungstic acid precipitates.

It is simple and direct, the products are stable for

storage at aqy stage, the F.S.H. is concentrated

ma~

times,
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dialysis removes a large percentage of the toxicit.y (probably

b.1 removal of salts), potency is not affected b,y detoxification,
Just as large or larger amounts of hormone are recovered with
this method.

The use of the mouse uterus as the endpoint for

the assay was established b.1 Levin and T,yndale (20).

This

proved to be a more accurate and more sensitive test than did
follicular enlargement, increase in ovarian weight or vaginal
canalization.

These authors established the absence of estro-

genic sUbstances in the urine by injections into spayed rats as
well as by the fact that all potency was destri.Jyed by heating,
acid treatment and other procedures which would not injure
estrin~had

it been present.

The uterine response was 67%

greater if mice were autopsied 72-hours after the first in jection.
The endometrial biopsies were made with a Novak curette,
after cleansing the cervix with Merthiolate.

The tissue ob-

tained was fixed with Formalin (10%), sectioned and stained
with H &'E. as a routine procedure of this clinic.

Classifica-

tion as to secretory or non-secretory activit,y is made on the
basis of the standard text books of Qynecology (Novak).

A.
B.
C.
D.
E.
F.

Acidified Filtered Urine with Alcohol Added.
First Precipitate.
Dialysis Process.
Dialysized Specimen with Alcohol Added.
Second Precipitate.
NaCl & Balance.

A.

Biopsies - sections.
Index File.
Mouse board - lco syringe - Specimen Bottles.
Usual t,ype breeding pan.
Autopsied mice.

~.

C.
D.
E.

V

PATIENT

I

LACTATION.AMENORRHEA. DATA

HISTORY ------:-- ---mopgy--- -~------F.S-:I!0¥UJ----- ---CCMtlENT

L.A.

Para iii (3/3/47).
Did not menstruate
24-yr. C.F. with prev. lact.
No preg. during
prev. laction.

WKS. PQST"PARTUM

5/2/47-Int. non-sec.
(s1. b;rperplasia).

~6.6
-26
-53
Lactating.
19.8mg. 4.4 mg. 4.4 mg. No menses.

8

5/16/47-Post. mens.
non-sec.

~6.6

~26
~53
Lactating.
79 mg. 38.2mg. 51 mg. No menses.
33.lmg. 26.3mg.

10

5/29/47-Int. non-sec.

~6.6

-53
Lactating
29.3 mg. 6.1 mg. 5.5mg. No menses.

12

6/13/47-Int. non-sec.

~6.6

14

6/30/47-Tnt. non-sec.

2. M.E.B.

Para iii 0/2/47). 4!11/47-Int. Non-sec.
3-days beg.
(s1. hyperplasia).
24-yr. C.F. 4/11/47. No cramp.
Did not mens. during 4/25/47-Int. non-sec.
lactation.
L.M.P.

-26

~26

69.2mg.

-53
Lactating.
21mgs. 6.5mg. r~o menses.

~6.6

-26

-53

L.M.P. 6/13 - 17fo47.

16

1-6.6
1-26
-53
Bleeding 3-days beg.
32.lmg. 15~2mg. 5.2mg. 4/11/41.

6

~6.6

8

~26

66 mg.

-53
Lactating.
19.1mg. 5.1 mg.

5/16/47-Post-mens.
non-sec.

~6.6

-26
-53
10.7 mg. 3mg.

Scant bleeding 1~
days beg. 5/11/47.
Lactating.

11

6/20/47-Int.non-sec.

~6.6

L.ll.P.

6/17/47.
Scant one ~.
Lactat:ing.

16

12.8

-26

mg. 5mg.

Itr-a

PATIENT

HI8TORY- --

3. L.B.

Para i (2/20/47).
Lactating.
27-yr. C.F. No menses.

U.

Para vi (2/6/47).
Lact. No menses.
29-yr. C.F. Did mens. during
prevo lact. Did
become pregnant
dur:ing a previous
lactation.
E.B.

5. R.C.

Para i (2/16/47)
Lactating.
16-yr. C.F. No menses.

BIOPSY-· --

F.8.H.~MU:J

414147-Int. non.sec.
81. hyperplasia.

1-6.6
8.4 mg.

4118/47-Int.nonsec.
(Thrombosis)

.

COMMENT

WKS :POST4PARTUM

Lactating.
-53
3.5 mg.

6

-6.6
-6.6
6.4 mg. 3.5mg.

Lactat:ing.

8

5/2/41-Int.non-sec.

1-6.6
2lmg.

-26
-53
4.5mg. 4.3mg.

Lactat:ing.
No menses.

10

5/16/47-Int. non-sec.

-26
1-6.6
-53
49.3mg. 3.3mg. 3.3mg.

Lactating.
No menses.

12

4111/47-Int. non-sec.

Lactating.
1-6.6
1-26
-53
40.8mg. 12.2mg. 5.J.ul1g.

4125/47-Int. non-sec.

1-6.6

5/9/47-Int. non-sec.

k.3mg.
-6.6
-6.6
5.1mg. 3.0 mg.

5/23/47-Int. non-sec.

1-6.6
-26
-53
9.2mg. 3.0mg. 3.2mg.

4.I4147-Int. non-sec.

1-6.6
1-26 -53
30.6rng. 20mB. 5.6mg.

7

4118/47-Int. non-sec.

Lactating.
1-6.6
1-26 -53
57.2mg. 10.2mg. 3.9mg. No menses.

9

-26

-S3

24.L1I1g. 5.2mg. 4.8mg.

9

Lactating.
No menses.

11

Lactating.
No menses.

13

Lactating.
No menses.

15

%%%

14-b

"\

PATIENT

BtSTORY

6. L.B.

Para U (1/25/47)
Lactating. No mens.
21-yr. C.F. No mens. during
prev. lactation.

BIOPSY

-- --COID:rnm

!V25/47-Int. non-sec. ~6.6 ~26
-53
Old decidual reaction. 27.7mg. 10.5mg.4.6mg.

WKS.PQST-PARTUM

Nursed 1st baby
9-mos. Mens.
@ 13-mos.

13

5/9/47-Int. non-sec.

~6.6

~26 -26 -53
Lactating.
33mg. 12mg. 3mg.3mg.3mg.No mens.

15

5/23/47-Int. non-sec.

~.6

6/6/41-Int. non-sec.

7. L.S.

-Y;;S~lr~MilT--~-

';'~6

Lactating.

4.lmg. No menses.

17

28.4mg. 20 ,,6mg.
~6.6

-53
Lactating.
4.3mg. No menses.

19

22 mg. 11mg.

-53

~26

-53

Para iT 0/8/47)

4!24/47-Int. Hon-sec.
(Atrop~ of stroma)

~6.6

-26

Para ii (3/12/47)
Lact. No mens.
No mens. or preg.
dur. pre v • lact.

5/9/41-Int. non-sec.

~6.6

-26
-53
31Omg. 3.0mg. 3.0mg.

8

36mg.
~6.6

~26

Lactating.
Irregular spotting.

7

42-yr. C.F.
8.

N.M.

27-yr. C.F.

5/23/47-Int. non-3ec.
6/27/47-Int. non-sec.

9.

P.R.

31-yr. C.F.

Para Ui 0/6/47)
Lact. No mens.
No.mens. or preg.
during prev.lact.

5/9/47-Int. non-sec.

-53
5.2mg

Lact. Exam shows
normal mens. flow.

10

19.8mg. 9.1mg.
~6.6

-53

L.M.P. 5/23/47.
One day. Lactating.
No period in June.

1.4

Pds. resumed I-mo.
after lact. stopped
with prevo preg.

9

-26

Specimen Toxic.

Mice died.

1.4-c

F.s.H.~1

PATIENT

mSTORY

10. E.K.

5/20/47-Int. non-sec. 14;6 1-26 -53
Para v 0/5/47)
Atrophy of endometrium. 35.3mg.10.3mg. 3.0 mg.
14-mos. post.-part.
no mens. Nursed
other babies 66/30/47-Int. non-sec. 1-6.6 1-26
-53
mos. Did not mens.
dur. lact. Resumed
Catamenia 3-mos after 'Weaning.

30-yr. C.F.

11. M.D.
21:"yr. C.F.

12.

C.G.

IS-yr. C.F.
13.

M.W.

BIOPSY

COMMENT

Para 11 (4/4/47)
Lact. No mens.
Did not nurse 1st.
baby. Catamenia
resumed @ 2~mos.
post-partum.

5/16/47-Int. non-sec.

1-6.6
36mg.

Para 1 (4/5/47)
Lactat:ing.
No mens.

5/23/47-Int. non-sec.
Thrombosis and
byanilization.

1-6.6

-26

10.lIng.

4.0mg.

Para 1 (4/10/47)
Lact. No mens.

5/23/47-Late Int. Sec. 1-6.6
35 mg.

WKS.POST-PARTUM

Lactating.
Breasts congested.

62

No menses.
Not lactating.

68

-26 -53
3.0mg. 3.0mg.
3.1 mg.

-53
3.6mg.

-26
-53
(Should mens.within
3.8mg. 3.6 mg. eight days.

6

7

6

20-yr. C.F.
6/l3/47-Int. non-sec.

1-6.6

1-26
-53
L.M.P. l!-days beg.
l2.2mg. 4.lmg. 5/24/47. Abscess of
breast rupt. sponte
Rx Stilbesterol 5-mg.
daily x 5.
Specimen Toxic
Not lactating.
Mice died.
Abscess healing.
L.M.P. 3-days beg.
1-6.6 1-26
-53
6/24/47. Scanty.
20 mg.

6/20/47-Int. non-sec.
6/zr/47-Int. non-sec.

9

10
11

14-d
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The data in the preceding chart

m~

be tabulated somewhat

as follows:
Thir~-four

F.S.H. determinations on 13 patients were

done and 36-biopsies are reported.

Two F.S.H. speci-

mens were toxic and the mice assayed with these samples
died before receiving the final injection.
The incidence of non-secretory endometrium was 97%
(35 biopsies).

The corresponding F.S.H.

ass~s

showed;

13

specimens positive for 6.6 Mu and negative for 26 Mu, and 17
specimens positive for 26 Mu but negative for 53 Mu, giving
a total of 30 F.S.H. specimens well within the normal limits
of daily output for regularly menstruating, non-pregnant, nonlactating women.

The incidence of normal F.S.H. in percent in

this series is therefore 91%.

Two F.S.H. levels (6%) were less

than 6.6 Mu per 24-hours and these were associB.ted with a nonsecretory endometrium.

One F.S.H. level (3%) was above 53 Mu

but below 85 Mu per 24-hours and this was associated with a nonsecretory endometrium.

All three patients showing other than

nornml F.S.H. levels on one occasion had at least 3 or 4 other
ass~s

with the normal levels.
One biopsy of late interval secretory endometrium was

obtained, the incidence being 3% (case 13).

This was associated

with a normal F.S.H. level (more than 6.6 Mu, less than 26 Mu
per 24-hours) and the patient had a

scan~

menstrual period

which began about 36-hours after the biops,y was taken.
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Four patients (30.7%)

had catamenia resumed during

this period of observation and o:f these, three were anovulatory and. one ovulatory in nature (case 1,2,8, & 13).

Nine

cases (69.3$) were complete amenorrheas throughout the period
of observation.
One patient with a breast abscess is interesting in that
at six weeks post-partum a biopsy of secretory endometrium was
obtained, and the patient
ning l!-days later.

t~d

a

scan~

menstrual period begin-

At 9 weeks the patient was seen again, at

which time she had a breast abscess which had ruptured spontaneousl¥ •

The endometrium on that day was non-secretory.

The

local breast lesion was treated and the patient given 5 mgm. of
Sti~besterol

dail¥ for 5 days to dry up her breasts, and the

bab.Y weaned.

At ten weeks post-partum (one month after the

secretory biopsy) this patient showed a non-secretory endometrium and four days later had a scanty 3-day menstrual period.
At 11 weeks post-partum the patient had a non-secretor,y endometrium.

It is suggested that this patient's second menstrual

c.ycle was anovulator,y in nature and that the dose of Stilbesterol
given to control lactation from the breasts was also sufficient
to inhibit oVUlation in that cycle. All F.S.H. assays on the
patient were normal.
One case of perSistent amenorrhea at 14-months post-partum
is presented (case 10).

This patient had two endometrial biopsies,

both of which were non-secretory, the first being ver,y atrophic.
Both F.H.S. assays were within normal levels (more than 26 Mu
and less than 53 Mu per 24-hours).

17
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DISCUSSION

In discussing this problem and the above data it is

necessary to consider the reclassification of the amenorrheas
in the light of our knowledge of F.S.H. which was presented b,y

,Albright.

There

may

be primary ovarian failure with

estrinism as in the case of menopause patients.

~po

In this group

F.S.H. is increased in the urine.

There may be secondar,y

ovarian failure with

due to pituitary gonad-

atrophin failure.
urine~

i.e.~

~poestrin1sm

In this group F.S.H. is decreased in the

Simmondfs cachexia.

A third group is now es-

tablished in which there is hypoestrinism with ovarian failure
associated with a normal F.S.H. output.

There is a psychic

factor present in this third group which cannot be

overlooked~

and it is conceivable that the hypothalamus is responsible in
this group for the release of some precursor of estrin via the
hypothalamic-pitultar,y pathway which is non-estrogenic and which
is inhibitory to F.S.H.

In

a~

case the level of F.S.H. in this

class of hypothalamic amenorrheas .is normal.
In animals it is established that coitus with subsequent

nervous impulses is responsible via the hypothalamic-pituitary
tract tor the release of luteinizing hormone (LH) necessary tor
ovu1ation but whether this is directlY applicable to humans is
not known.

We do know that F.S.H. causes ripening of ovarian

follicles, that F.S.H. plus L.H. causes the follicle to produce
estrin and to cause
-fovulation~ that L.H. causes corpus luteum formation and that
L.H. plus luteotropin causes the corpus luteum to produce
progesterone (17).
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It then becomes evident to suspect that amenorrhea
associated with a normal F.S.H. output

may

be the result Qf

dysfunction of the hwpothalamic-pituitary nervous pathway
governing the release of prolactin and L.H.
The predominance of a non-secretory endometrium in contrast to a secretory endometrium may indicate an absence of a
functioning corpus luteum as

previous~

speculated.

The inci-

dence of non-secretory and secretory endometrium in this series
is consistent with that found b.1 Topkins in a larger series.
The incidence of a normal F.S.H. in over 90% of specimens
would indicate that this factor of the anterior pituitary is
not suppressed during lactation and that lack of ovulation and
menstruation cannot be explained on the basis of lack of follicular maturation.

This finding is consistent with the unpublished data
supplied Qy Dr. Anne Forbes concerning 9 assays of F.S.H. done
on lactating women in Dr. Fuller Albright's laboratory.

All

9 of these assays were within the normal levels as stated herein,
(personal communication).

19
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CONCLUSIONS

From this study the only conclusions Justified are:
1. that the anterior-p1tuitary gland output of F.S.H. during
lactation is normal in 90% of cases;

2. that there is no

relation between this level of F.S.H. and the incidence of
menstruation or ovulation during lactation;

3.

that the

amenorrhea of lactation is not due to failure of the follicle
to receive its growth stimulus.
It may be Justifiable to suppose that the amenorrhea of
lactation

may

be due to a lack of L.H. or luteotropin and that

a~pothalamic-pituitar.y

nervous mechanism may be responsible

for this.
Vlll

SUMMARY

The problem of the amenorrhea associated with lactation
is presented, the literature reviewed and the incidence of
catamenia discussed.

Thirteen cases oflactation amenorrhea,

complete and incomplete, are studied and reports of 36 endometrial biopsies and 34 F.S.H.
of

non~secretor,y

endometrium 3%.
is 91%.

ass~s

are given.

The incidence

endometrium is found to be 97%, of secretDr,y
The incidence of normal daily levels of F.S.H.

Six~-nine

percent mf patients were complete amenorrheas

and 31% had catamenia re-establ1shed during the period of observation.

The significance of the observations are considered and

it is concluded that the amenorrhea of lactation is not due to
suppression of the anterior p1tuitar,y
factor.

i'o~licle

stimulating
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